Latest Articles

Publication Date
Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases.

This project developed eligibility criteria for menopausal hormone therapy in patients with medical conditions beyond those published in a previous report. A new consortium of scientific societies coordinated by the …

Published: Jan. 30, 2025, midnight
Rare malignant ovarian tumors: a review.

There are many histologic types of gynecologic malignancies. I reviewed three rare ovarian tumor types that have poor prognoses. Ovarian mesonephric-like adenocarcinoma (MLA) is a newly described histological type known …

Published: Jan. 29, 2025, midnight
Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions.

Published: Jan. 29, 2025, midnight
Dr Hinchcliff on the Addition of Dostarlimab to Chemotherapy in Advanced/Recurrent Endometrial Cancer - OncLive

Dr Hinchcliff on the Addition of Dostarlimab to Chemotherapy in Advanced/Recurrent Endometrial Cancer OncLive

Published: Jan. 27, 2025, 8:21 p.m.
Primary Carcinomas of the Episiotomy Scar Site: A Systematic Literature Review.

Episiotomy is a perineal incision enlarging the vaginal opening during labor, preventing severe perineal/vaginal/ano-rectal lacerations. We performed a systematic literature review (PRISMA guidelines; Pubmed, Scopus and Web of Science databases) …

Published: Jan. 26, 2025, midnight
(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment - ResearchGate

(PDF) Predicting immunotherapy efficacy in endometrial cancer: focus on the tumor microenvironment ResearchGate

Published: Jan. 25, 2025, 1:07 p.m.
Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm.

Endometriosis is a chronic inflammatory estrogen-dependent disease affecting 10% of women worldwide leading to chronic pelvic pain and infertility which may be treated clinically or surgically.

Published: Jan. 25, 2025, midnight
€26.5M Series B Funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup - ArcticStartup

€26.5M Series B Funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup ArcticStartup

Published: Jan. 24, 2025, 12:51 p.m.
€26.5M Series B funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup - ArcticStartup

€26.5M Series B funding pushes Swedish company's endometriosis therapy to next stage - ArcticStartup ArcticStartup

Published: Jan. 24, 2025, 12:51 p.m.
Pathogenesis, Diagnosis, and Management of Inguinal Endometriosis: A Case Series of Six Patients.

Inguinal endometriosis is a less common form of endometriosis. Therefore, there is no consensus regarding its pathogenesis or treatment. In this study, we retrospectively reviewed the pathogenesis and treatment of …

Published: Jan. 24, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!